Nitin Khosla, MD, and colleagues at Rush University Medical Center (Chicago, Illinois), reviewed 2000 charts from patients referred to the University's Hypertension/Clinical Research Center. All of ...

Please provide your email address to receive an email when new articles are posted on . Longer use of hydrochlorothiazide was linked to an increased risk for keratinocyte carcinoma and melanoma.

SaveHealth reports on 10 hypertension medications, their classifications, effectiveness, side effects, and safety in managing ...

Dear Dr. Roach: I am an 88-year-old man in quite good health. I spend at least 30 hours a week doing yard work. I have had high blood calcium for many years, usually around 10.7. I take pravastatin ...

Dear Dr. Roach: I am an 88-year-old man in quite good health. I spend at least 30 hours a week doing yard work. I have had high blood calcium for many years, usually around 10.7. I take pravastatin ...

The Kobe combination therapy of losartan plus HCTZ (losartan/HCTZ), effect and safety trial (Kobe-CONNECT) Study was designed to compare the effectiveness and safety of losartan/HCTZ with that of the ...

Speaking with heartwire, Bakris said clinicians previously believed marrying diuretic therapy to an ACE inhibitor or angiotensin receptor blocker (ARB) might provide protection from new-onset diabetes ...

The incidence of kidney stone recurrence did not significantly differ among patients who received hydrochlorothiazide compared with those who received placebo, according to a study published in The ...

NEW ORLEANS, LA—For black patients in sub-Saharan Africa, adding amlodipine to either hydrochlorothiazide (HCTZ) or perindopril is the best way to reduce blood pressure over 6 months, according to ...

Triamterene 37.5mg, hydrochlorothiazide 25mg; caps. Triamterene exerts its diuretic effect on the distal renal tubule to inhibit the reabsorption of sodium in exchange for potassium and hydrogen ions.

A common diuretic wasn't much help for staving off recurrent kidney stones, the NOSTONE trial showed. Over a median follow-up of 2.9 years, symptomatic or radiologic recurrence of kidney stones ...